Juvenile rheumatoid arthritis (unspecified type, with or without rheumatoid factor) affecting a documented anatomical site that does not match any of the other specific site subcode options in the M08.0 family.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 9
- Region
- Other
Documentation tips
What should appear in the chart to support M08.0A.
Source · Editorial brief grounded in 5 cited references ↓
- Name the specific affected site explicitly (e.g., 'temporomandibular joint,' 'sternoclavicular joint') — 'other specified site' requires the site to be documented, not inferred.
- State the arthritis subtype clearly or document why subtype has not yet been determined; if systemic, polyarticular, or pauciarticular onset is known, a more specific code applies.
- Document rheumatoid factor status (positive or negative) even though M08.0A encompasses both — this supports medical necessity for DMARD or biologic therapy authorization.
- Record any associated systemic conditions (e.g., IBD) and code them separately per the M08 'Code Also' instruction.
- Include the patient's age at diagnosis onset; JRA/JIA codes require onset before age 16 to be appropriate.
Related CPT procedures
Procedure codes commonly billed with M08.0A. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M08.0A and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M08.0A when the affected joint has its own specific subcode — check the full M08.0 series first; 'other specified site' is a true residual category, not a shortcut.
- Defaulting to M08.0A instead of M08.9A (juvenile arthritis, unspecified, other specified site) when the arthritis subtype itself is also unspecified — M08.0 implies JRA specifically, while M08.9 is for unclassified juvenile arthritis.
- Omitting the required 'Code Also' for comorbid Crohn's disease or ulcerative colitis when present, which can trigger audit flags and medical necessity denials.
- Assigning M08.0A for psoriatic juvenile arthropathy or Felty's syndrome — both are Excludes1 under M08 and require entirely separate codes (L40.54 and M05.0 respectively).
- Failing to update the diagnosis code when subtype is subsequently confirmed — M08.0A should be replaced once systemic, polyarticular, or pauciarticular onset is documented.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M08.0A applies when a patient under 16 years of age carries a diagnosis of juvenile rheumatoid arthritis — unspecified subtype, meaning systemic onset, polyarticular, and pauciarticular subtypes have not been confirmed — and the affected joint or site is an 'other specified' location not captured by the standard laterality subcodes (e.g., not shoulder, elbow, wrist, hand, hip, knee, ankle, or vertebrae as individually listed). Typical examples might include temporomandibular joint involvement, sternoclavicular joint, or other atypical sites explicitly documented by the treating provider.
This code sits under parent M08.0 (Unspecified juvenile rheumatoid arthritis), which carries an Applicable To note covering juvenile rheumatoid arthritis with or without rheumatoid factor. Before assigning M08.0A, confirm the subtype is genuinely unspecified — if systemic onset is documented, M08.2x applies; polyarticular RF-positive maps to M08.0x variants; pauciarticular to M08.4x. The code is also listed by CMS as supporting medical necessity for rituximab (J9311, J9312, Q5115), so accurate subtype and site specificity directly affects biologic drug coverage determinations.
The M08 category requires a 'Code Also' for any associated underlying condition such as Crohn's disease (K50.-) or ulcerative colitis (K51.-). Exclude psoriatic juvenile arthropathy (L40.54), juvenile dermatomyositis (M33.0-), and Felty's syndrome (M05.0) — those are Excludes1 conditions and cannot be coded alongside M08.0A for the same manifestation.
Sibling codes
Other billable codes under M08.0 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What makes a site qualify as 'other specified' for M08.0A versus using a different M08.0 subcode?
02Can M08.0A be used for adult patients diagnosed with JRA in childhood?
03Is M08.0A accepted by CMS for rituximab coverage?
04What is the difference between M08.0A and M08.9A?
05Do I need to code associated IBD separately when using M08.0A?
06When was M08.0A added to ICD-10-CM?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M08-/M08.0A
- 03cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=56380&ver=53
- 04vsac.nlm.nih.govhttps://vsac.nlm.nih.gov/context/cs/codesystem/ICD10CM/version/2023/code/M08.0A/info
- 05aapc.comhttps://www.aapc.com/codes/icd-10-codes/M08
Mira AI Scribe
The Mira AI Scribe captures the patient's age at arthritis onset, the precise joint or anatomical site involved, RF lab result, any documented subtype characterization, and associated conditions like IBD. This prevents a downcode to nonbillable M08.0 or a mismatch to a wrong subtype code — both of which can stall biologic drug prior authorizations that cite M08.0A as a covered diagnosis under CMS rituximab policy.
See how Mira captures M08.0A documentation